SUDA PHARMACEUTICALS LTD

INVESTOR PRESENTATION - SUDA PHARMACEUTICALS LTD

ASX:SUD

SUDA PHARMACEUTICALS LTD

Health Care

SUDA Pharmaceuticals Ltd (SUDA), based in Australia and the US, is a world leader in reformulating and delivering medication through the oral mucosa. Patients typically take medication as pills, tablets or capsules yet less than 25% of the medication is absorbed into the bloodstream. SUDA can increase the bioavailability of administered medications, which means it increases the amount of the drug absorbed by the body so is able to increase the effect of that drug.

Read more

Market Cap

10.81m

Price at Close

$0.038

4w avg. Volume

14.01m

4w avg. Turnover

$918.35k

Announcements
announcementt+2 movementdate
  • Placement Offer Completed and Appendix 2A

    Issued Capital

  • -7.14%

    10 Aug 2020

-7.14%

10 Aug 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • -6.82%

    07 Aug 2020

-6.82%

07 Aug 2020
  • Distribution of Security Holders

    Periodic Reports

  • +2.33%

    05 Aug 2020

+2.33%

05 Aug 2020
  • Prospectus

    Issued Capital · Market sensitive

  • +2.33%

    05 Aug 2020

+2.33%

05 Aug 2020
  • Top 20 securityholders

    Periodic Reports

  • +2.33%

    05 Aug 2020

+2.33%

05 Aug 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • +2.33%

    05 Aug 2020

+2.33%

05 Aug 2020
  • Entitlement Offer Completed and Appendix 2A

    Issued Capital

  • +2.33%

    05 Aug 2020

+2.33%

05 Aug 2020
  • Proposed issue of Securities - SUD

    Issued Capital

  • -6.98%

    03 Aug 2020

-6.98%

03 Aug 2020
  • Becoming a substantial holder

    Shareholder Details

  • -6.98%

    03 Aug 2020

-6.98%

03 Aug 2020
  • Entitlement Offer Closes Significantly Oversubscribed

    Issued Capital

  • -6.98%

    03 Aug 2020

-6.98%

03 Aug 2020
Market Data

Current Price

$0.038

52WK HIGH

$0.097

52WK LOW

$0.002

1YR RETURN

+850.00%

1YR RETURN VS. SECTOR

+827.87%

90 DAY RETURN

0.00%

ASX RANK

1,584

/2,032

SECTOR RANK

27

/32

SHARES OUTSTANDING

284.51m
ASX:SUD

SUDA PHARMACEUTICALS LTD

Health Care

SUDA Pharmaceuticals Ltd (SUDA), based in Australia and the US, is a world leader in reformulating and delivering medication through the oral mucosa. Patients typically take medication as pills, tablets or capsules yet less than 25% of the medication is absorbed into the bloodstream. SUDA can increase the bioavailability of administered medications, which means it increases the amount of the drug absorbed by the body so is able to increase the effect of that drug.

Read more

Market Cap

10.81m

Price at Close

$0.038

4w avg. Volume

14.01m

4w avg. Turnover

$918.35k

ASX:SUD is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

(03) 9028 2888

deals@freshequities.com

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.